|
Video: What is a Stock Split?
|
|
Cortexyme is a clinical stage biopharmaceutical company focused on therapeutic approaches to improve the lives of patients diagnosed with Alzheimer's and other degenerative diseases. Co.'s portfolio of gingipain inhibitors are orally administered, brain-penetrating small molecules. Co.'s pipeline includes proprietary drug candidates for the treatment of CNS disorders including Alzheimer's disease, for the treatment of oncology applications including the prevention of oral squamous cell carcinoma, and for the treatment of conditions like periodontitis. Co.'s pipeline also includes proprietary irreversible protease inhibitors under development for the treatment of coronavirus infection. According to our CRTX split history records, CRTX has had 1 split. | |
|
CRTX (CRTX) has 1 split in our CRTX split history database. The split for CRTX took place on November 03, 2008. This was a 1 for 10 reverse split, meaning for each 10 shares of CRTX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as CRTX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CRTX split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CRTX shares, starting with a $10,000 purchase of CRTX, presented on a split-history-adjusted basis factoring in the complete CRTX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/10/2019 |
|
End date: |
07/29/2022 |
|
Start price/share: |
$23.86 |
|
End price/share: |
$1.95 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-91.83% |
|
Average Annual Total Return: |
-54.04% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$816.99 |
|
Years: |
3.22 |
|
|
|
Date |
Ratio |
11/03/2008 | 1 for 10 |
|
|